Raised EBITDA and FOCF forecast for fiscal year 2020

Globe Newswire

World Obstructive Sleep Apnea Epidemiology and Forecasts to 2030

Dublin, Dec. 09, 2020 (GLOBE NEWSWIRE) — The “Obstructive Sleep Apnea Market Insights, Epidemiology, and Market Forecast – 2030” drug pipelines has been added to ResearchAndMarkets.com’s offering. The Obstructive Sleep Apnea market report provides analysis regarding current treatment practices, emerging drug-like AD036 and AD128 (Apnimed) and BAY2586116 (Bayer’s) potential therapies, market share of the individual therapies, historical, current, and forecasted Obstructive Sleep Apnea market size from 2017 to 2030 segmented by seven major markets.The report also covers current Obstructive Sleep Apnea treatment practice/algorithm, market drivers, market barriers, and unmet medical needs to curate the best of the opportunities and assess the market’s underlying potential.Report Highlights In the coming years, the Obstructive Sleep Apnea market scenario is expected to alter across the 7MM due to the launch of a better therapy covering the drawbacks of the standard of care.The in-depth analysis of the pipeline assets across different stages of development (Phase II), different emerging trends, and comparative analysis of pipeline products with detailed clinical profiles, launch date along with product development activities will support the clients in the decision-making process regarding their therapeutic portfolio by identifying the overall scenario of the research and development activities. Obstructive Sleep Apnea Report Insights Patient PopulationTherapeutic ApproachesObstructive Sleep Apnea Pipeline AnalysisObstructive Sleep Apnea Market Size and TrendsMarket OpportunitiesImpact of upcoming Therapies Obstructive Sleep Apnea Report Key Strengths 11 years Forecast7MM CoverageObstructive Sleep Apnea Epidemiology SegmentationKey Cross CompetitionHighly Analyzed MarketDrugs Uptake Obstructive Sleep Apnea Report Assessment Pipeline Product ProfilesKey Products and Key PlayersMarket Drivers and Barriers Key QuestionsMarket Insights: What was the Obstructive Sleep Apnea market share (%) distribution in 2017, and how it would look in 2030?What would be the Obstructive Sleep Apnea total market size and market size by therapies across the 7MM during the forecast period (2017-2030)?What are the key findings pertaining to the market across 7MM, and which country will have the largest Obstructive Sleep Apnea market size during the forecast period (2017-2030)?At what CAGR, the Obstructive Sleep Apnea market is expected to grow in 7MM during the forecast period (2017-2030)?What would be the Obstructive Sleep Apnea market outlook across the 7MM during the forecast period (2017-2030)?What would be the Obstructive Sleep Apnea market growth till 2030, and what will be the resultant market size in the year 2030?How would the market drivers, barriers, and future opportunities affect the market dynamics and subsequent analysis of the associated trends? Epidemiology Insights: What are the disease risks, burdens, and unmet needs of obstructive sleep apnea?What is the historical obstructive sleep apnea patient pool in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan?What would be the forecasted patient pool of obstructive sleep apnea in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan?What will be the growth opportunities in the 7MM with respect to the patient population pertaining to obstructive sleep apnea?Out of all 7MM countries, which country would have the highest prevalent obstructive sleep apnea population during the forecast period (2017-2030)?At what CAGR the population is expected to grow in 7MM during the forecast period (2017-2030)? Current Treatment Scenario, Marketed Drugs, and Emerging Therapies: What are the current options for the obstructive sleep apnea treatment, along with the approved therapy?What are the current treatment guidelines for treating obstructive sleep apnea in the USA, Europe, and Japan?What is the obstructive sleep apnea marketed drugs and their MOA, regulatory milestones, product development activities, advantages, disadvantages, safety and efficacy, etc.?How many companies are developing therapies for the treatment of obstructive sleep apnea?How many therapies are developed by each company for obstructive sleep apnea treatment?How many are emerging therapies in mid-stage and late-stage of development for obstructive sleep apnea treatment?What are the key collaborations (Industry-Industry, Industry-Academia), Mergers and acquisitions, licensing activities related to obstructive sleep apnea therapies?What are the recent novel therapies, targets, mechanisms of action, and technologies developed to overcome the limitation of existing therapies?What are the clinical studies going on for obstructive sleep apnea and their status?What are the key designations that have been granted for the emerging therapies for obstructive sleep apnea?What are the global historical and forecasted market of obstructive sleep apnea? Companies Mentioned Teva PharmaceuticalsJazz PharmaceuticalsIdorsia PharmaceuticalsBayerApnimed For more information about this drug pipelines report visit https://www.researchandmarkets.com/r/gkx3eb About ResearchAndMarkets.com ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research. CONTACT:
CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Source link

Add a Comment